心源性休克的诊断与治疗进展  

Advances in diagnosis and treatment of cardiogenic shock

作　　者：刘妍[1] 崔北辰 王聪[1] Liu Yan;Cui Beichen;Wang Cong(Beijing Jishuitan Hospital,Beijing,China)

机构地区：[1]北京积水潭医院

出　　处：《实用休克杂志（中英文）》2022年第2期70-75,共6页Journal of Practical Shock

基　　金：首都卫生发展科研专项(项目编号:首发2022-2-2073)。

摘　　要：心源性休克(cardiogenic shock, CS)是难治的危重心血管疾病,尽管血运重建治疗、机械循环支持(mechanical circulatory support, MCS)治疗技术等不断发展并运用于临床,但心源性休克仍有较高的死亡率。本文旨在对近年来心源性休克的概述、临床分期及治疗方面做一述评,以期为临床心源性休克的诊治提供方向。Cardiogenic shock(CS)is a critical cardiovascular disease that is difficult to treat. Although revascularization therapy and mechanical circulatory support(MCS) therapy are continuously developed and applied in clinic, cardiogenic shock still has a high mortality. This paper aims to review the concept, clinical stage and treatment of cardiogenic shock in recent years, in order to provide direction for the diagnosis and treatment of clinical cardiogenic shock.

关 键 词：心源性休克 分期 诊断 治疗 机械循环支持 

分 类 号：R541.64[医药卫生—心血管疾病]